Contributors

Contributors Recent News

Is It Worth Investing in K12 Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Redfin Recently Broke Out Above the 200-Day Moving Average
After reaching an important support level, Redfin (NASDAQ: RDFN) could be a good stock pick from a technical perspective. RDFN surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.
FMC Corp Teams Up With AgroSpheres for Bioinsecticides
FMC Corporation (NYSE: FMC) recently entered into a research partnership with AgroSpheres, a biotechnology firm dedicated to sustainable crop protection and health.
Galaxy Digital Holdings' Revenue, Profit Grow, Buoyed by Record Mining Revenue
Galaxy Digital Holdings (OTC: BRPHF) revenue and profits jumped during the first quarter, bolstered by its mining operation's record performance amid the run-up in cryptocurrency prices.
How Brokers Can Prepare for the Impending Market Turn
The freight recession has officially dragged on longer than the COVID boom, and brokers are feeling the pinch of chronically suppressed margins.
Polymarket Raises $45 Million from Peter Thiel's Founders Fund, Vitalik Buterin and Others
Polymarket Labs has raised a $45 million Series B funding round led by Peter Thiel's Founders Fund and existing investors 1confirmation and ParaFi, with participation from Ethereum (CRYPTO: ETH) co-founder Vitalik Buterin, Dragonfly (NASDAQ:
Merck Ends Keytruda Combo Melanoma Study Due to Futility
Merck (NYSE: MRK) announced that it is discontinuing a cohort of the phase III study evaluating a co-formulation of its blockbuster PD-L1 inhibitor, Keytruda plus vibostolimab, its investigational anti-TIGIT antibody, as adjuvant treatment for patients with resected high-risk melanoma.
Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates
Alimera Sciences (NASDAQ: ALIM) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.71 per share a year ago. These figures are adjusted for non-recurring items.
Pyxis Oncology, Inc. Reports Q1 Loss, Tops Revenue Estimates
Pyxis Oncology, Inc. (NASDAQ: PYXS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.
Should You Buy Consolidated Water Ahead of Earnings?
Investors are always looking for stocks that are poised to beat at earnings season and Consolidated Water Co. Ltd. (NASDAQ: CWCO) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Is a Surprise Coming for Walmart This Earnings Season?
Investors are always looking for stocks that are poised to beat at earnings season and Walmart Inc. (NYSE: WMT) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Forward Air Books Big Loss in Post-Merger Q1; Stock Drops 30% Premarket
This story has been updated to include commentary from the company's Thursday call with analysts. Shares of Forward Air (NASDAQ: FWRD) plunged 30% in pre-market trading Thursday following a rough first-quarter report that was issued five hours after Wednesday's market close.</
Airfreight Rides E-Commerce to Surprise Growth in May
Conventional thinking suggests the unexpected strength of the air cargo market so far this year is ready to cool off for the summer, as freight activity normally does each year.
Should Invesco S&P MidCap 400 Revenue ETF Be on Your Investing Radar?
Designed to provide broad exposure to the Mid Cap Value segment of the US equity market, the Invesco S&P MidCap 400 Revenue ETF (ARCA:RWK) is a passively managed exchange traded fund launched on 02/22/2008.
Explorer Gets Conditional Approval for Chile Copper Project Deal
Source: Streetwise Reports 05/07/2024
Copper: The India Factor
Source: Michael Ballanger 05/06/2024
Ligand Moves to Strong Buy: Rationale Behind the Upgrade
Investors might want to bet on Ligand Pharmaceuticals (NASDAQ: LGND), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
New York Times Co. is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way.
Are Transportation Stocks Lagging Alaska Air Group This Year?
The Transportation group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Alaska Air Group (NYSE: ALK) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Is AppLovin Stock Outpacing Its Business Services Peers This Year?
The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has AppLovin (NASDAQ: APP) been one of those stocks this year?
Borderlands Mexico: Tractor-Trailer Thefts in Mexico Totaled 153 in April
Tractor-trailer thefts in Mexico totaled 153 in April In April, Mexico averaged about five cargo truck thefts per day, totaling 153 incidents across the country's roadways, according to the National Association of Vehicle Tracking and Protection Companies (ANERPV).
Should You Invest in the First Trust Indxx NextG ETF?
Looking for broad exposure to the Technology - Telecom segment of the equity market? You should consider the First Trust Indxx NextG ETF (NASDAQ: NXTG), a passively managed exchange traded fund launched on 02/17/2011.
Moving Average Crossovers Suggest The Bull Is Back
By Lance Roberts